{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:36:19Z","timestamp":1767990979133,"version":"3.49.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,3,10]],"date-time":"2018-03-10T00:00:00Z","timestamp":1520640000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s10067-018-4062-x","type":"journal-article","created":{"date-parts":[[2018,3,10]],"date-time":"2018-03-10T10:55:25Z","timestamp":1520679325000},"page":"875-884","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Anti-neutrophil cytoplasmic antibodies and their clinical significance"],"prefix":"10.1007","volume":"37","author":[{"given":"Supaporn","family":"Suwanchote","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muanpetch","family":"Rachayon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pongsawat","family":"Rodsaward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jongkonnee","family":"Wongpiyabovorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tawatchai","family":"Deekajorndech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen L.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven W.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael W.","family":"Beresford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawinee","family":"Rerknimitr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Direkrit","family":"Chiewchengchol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,10]]},"reference":[{"issue":"6342","key":"4062_CR1","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1136\/bmj.285.6342.606","volume":"285","author":"DJ Davies","year":"1982","unstructured":"Davies DJ, Moran JE, Niall JF, Ryan GB (1982) Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? Br Med J (Clin Res Ed) 285(6342):606","journal-title":"Br Med J (Clin Res Ed)"},{"key":"4062_CR2","doi-asserted-by":"crossref","unstructured":"van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA, van der Giessen M, van der Hem GK, The TH (1985) Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1 (8426):425\u2013429","DOI":"10.1016\/S0140-6736(85)91147-X"},{"key":"4062_CR3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s40620-017-0412-z","volume":"31","author":"V Binda","year":"2017","unstructured":"Binda V, Moroni G, Messa P (2017) ANCA-associated vasculitis with renal involvement. Journal of Nephrology 31:197\u2013208. https:\/\/doi.org\/10.1007\/s40620-017-0412-z","journal-title":"Journal of Nephrology"},{"issue":"1","key":"4062_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65(1):1\u201311. https:\/\/doi.org\/10.1002\/art.37715","journal-title":"Arthritis Rheum"},{"issue":"4","key":"4062_CR5","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1093\/ajcp\/111.4.507","volume":"111","author":"J Savige","year":"1999","unstructured":"Savige J, Gillis D, Benson E, Davies D, Esnault V, Falk RJ, Hagen EC, Jayne D, Jennette JC, Paspaliaris B, Pollock W, Pusey C, Savage CO, Silvestrini R, van der Woude F, Wieslander J, Wiik A (1999) International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol 111(4):507\u2013513","journal-title":"Am J Clin Pathol"},{"key":"4062_CR6","doi-asserted-by":"publisher","unstructured":"Rasmussen N, Wiik A, Jayne DR (2015) A historical essay on detection of anti-neutrophil cytoplasmic antibodies. Nephrol Dial Transplant 30 Suppl 1:i8\u201313. doi: https:\/\/doi.org\/10.1093\/ndt\/gfv070","DOI":"10.1093\/ndt\/gfv070"},{"issue":"5","key":"4062_CR7","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10157-012-0735-y","volume":"17","author":"E Csernok","year":"2013","unstructured":"Csernok E (2013) ANCA testing: the current stage and perspectives. Clin Exp Nephrol 17(5):615\u2013618. https:\/\/doi.org\/10.1007\/s10157-012-0735-y","journal-title":"Clin Exp Nephrol"},{"issue":"6","key":"4062_CR8","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/1529-0131(200012)13:6<424::AID-ART14>3.0.CO;2-Q","volume":"13","author":"JH Stone","year":"2000","unstructured":"Stone JH, Talor M, Stebbing J, Uhlfelder ML, Rose NR, Carson KA, Hellmann DB, Burek CL (2000) Test characteristics of immunofluorescence and ELISA tests in 856 consecutive patients with possible ANCA-associated conditions. Arthritis Care Res 13(6):424\u2013434","journal-title":"Arthritis Care Res"},{"issue":"9","key":"4062_CR9","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1001\/jama.2016.8307","volume":"316","author":"VL Bui","year":"2016","unstructured":"Bui VL, Kermani TA (2016) Clinical significance of a positive antineutrophil cytoplasmic antibody (ANCA) test. JAMA 316(9):984\u2013985. https:\/\/doi.org\/10.1001\/jama.2016.8307","journal-title":"JAMA"},{"issue":"8","key":"4062_CR10","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1177\/0961203316640921","volume":"25","author":"TY Avery","year":"2016","unstructured":"Avery TY, Bons J, van Paassen P, Damoiseaux J (2016) Diagnostic ANCA algorithms in daily clinical practice: evidence, experience, and effectiveness. Lupus 25(8):917\u2013924. https:\/\/doi.org\/10.1177\/0961203316640921","journal-title":"Lupus"},{"issue":"2","key":"4062_CR11","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1093\/rheumatology\/keh028","volume":"43","author":"E Csernok","year":"2004","unstructured":"Csernok E, Holle J, Hellmich B, Willem J, Tervaert C, Kallenberg CG, Limburg PC, Niles J, Pan G, Specks U, Westman K, Wieslander J, De Groot K, Gross WL (2004) Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener\u2019s granulomatosis: first results from a multicentre study. Rheumatology (Oxford) 43(2):174\u2013180. https:\/\/doi.org\/10.1093\/rheumatology\/keh028","journal-title":"Rheumatology (Oxford)"},{"key":"4062_CR12","doi-asserted-by":"publisher","unstructured":"Tervaert JW, Damoiseaux J (2009) Fifty years of antineutrophil cytoplasmic antibodies (ANCA) testing: do we need to revise the international consensus statement on testing and reporting on ANCA? APMIS Suppl 117(127):55\u201359. https:\/\/doi.org\/10.1111\/j.1600-0463.2009.02478.x","DOI":"10.1111\/j.1600-0463.2009.02478.x"},{"issue":"1 Suppl 70","key":"4062_CR13","first-page":"S66","volume":"30","author":"JU Holle","year":"2012","unstructured":"Holle JU, Herrmann K, Gross WL, Csernok E (2012) Comparative analysis of different commercial ELISA systems for the detection of anti-neutrophil cytoplasm antibodies in ANCA-associated vasculitides. Clin Exp Rheumatol 30(1 Suppl 70):S66\u2013S69","journal-title":"Clin Exp Rheumatol"},{"key":"4062_CR14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1749-6632.2009.04649.x","volume":"1173","author":"D Roggenbuck","year":"2009","unstructured":"Roggenbuck D, Buettner T, Hoffmann L, Schmechta H, Reinhold D, Conrad K (2009) High-sensitivity detection of autoantibodies against proteinase-3 by a novel third-generation enzyme-linked immunosorbent assay. Ann N Y Acad Sci 1173:41\u201346. https:\/\/doi.org\/10.1111\/j.1749-6632.2009.04649.x","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"4062_CR15","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ejim.2013.11.011","volume":"25","author":"AA Joode de","year":"2014","unstructured":"de Joode AA, Roozendaal C, van der Leij MJ, Bungener LB, Sanders JS, Stegeman CA (2014) Performance of two strategies for urgent ANCA and anti-GBM analysis in vasculitis. Eur J Intern Med 25(2):182\u2013186. https:\/\/doi.org\/10.1016\/j.ejim.2013.11.011","journal-title":"Eur J Intern Med"},{"issue":"3","key":"4062_CR16","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1046\/j.1523-1755.1998.00807.x","volume":"53","author":"EC Hagen","year":"1998","unstructured":"Hagen EC, Daha MR, Hermans J, Andrassy K, Csernok E, Gaskin G, Lesavre P, L\u00fcdemann J, Rasmussen N, Sinico RA, Wiik A, van der Woude FJ, for the ECBCRPfAAS (1998) Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. Kidney International 53(3):743\u2013753. https:\/\/doi.org\/10.1046\/j.1523-1755.1998.00807.x","journal-title":"Kidney International"},{"issue":"1","key":"4062_CR17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/jcla.20204","volume":"22","author":"Z Feng","year":"2008","unstructured":"Feng Z, Liu P, Li Z, Sui B (2008) Clinical relevance of anti-PR3 capture ELISA in diagnosing Wegener\u2019s granulomatosis. J Clin Lab Anal 22(1):73\u201376. https:\/\/doi.org\/10.1002\/jcla.20204","journal-title":"J Clin Lab Anal"},{"issue":"11","key":"4062_CR18","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.3346\/jkms.2013.28.11.1690","volume":"28","author":"SH Kim","year":"2013","unstructured":"Kim SH, Park J, Bae JH, Cho MS, Park KD, Jeong JH (2013) ANCA-negative Wegener\u2019s granulomatosis with multiple lower cranial nerve palsies. J Korean Med Sci 28(11):1690\u20131696. https:\/\/doi.org\/10.3346\/jkms.2013.28.11.1690","journal-title":"J Korean Med Sci"},{"issue":"7","key":"4062_CR19","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1182\/blood.V94.7.2487.419k07_2487_2496","volume":"94","author":"V Witko-Sarsat","year":"1999","unstructured":"Witko-Sarsat V, Cramer EM, Hieblot C, Guichard J, Nusbaum P, Lopez S, Lesavre P, Halbwachs-Mecarelli L (1999) Presence of proteinase 3 in secretory vesicles: evidence of a novel, highly mobilizable intracellular pool distinct from azurophil granules. Blood 94(7):2487\u20132496","journal-title":"Blood"},{"key":"4062_CR20","doi-asserted-by":"publisher","first-page":"185416","DOI":"10.1155\/2014\/185416","volume":"2014","author":"J Schulte-Pelkum","year":"2014","unstructured":"Schulte-Pelkum J, Radice A, Norman GL, Lomicronpez Hoyos M, Lakos G, Buchner C, Musset L, Miyara M, Stinton L, Mahler M (2014) Novel clinical and diagnostic aspects of antineutrophil cytoplasmic antibodies. J Immunol Res 2014:185416\u2013185412. https:\/\/doi.org\/10.1155\/2014\/185416","journal-title":"J Immunol Res"},{"issue":"10","key":"4062_CR21","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/nrrheum.2016.123","volume":"12","author":"D Cornec","year":"2016","unstructured":"Cornec D, Cornec-Le Gall E, Fervenza FC, Specks U (2016) ANCA-associated vasculitis\u2014clinical utility of using ANCA specificity to classify patients. Nat Rev Rheumatol 12(10):570\u2013579. https:\/\/doi.org\/10.1038\/nrrheum.2016.123","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"4062_CR22","doi-asserted-by":"publisher","first-page":"258","DOI":"10.20524\/aog.2016.0028","volume":"29","author":"KS Kyriakidi","year":"2016","unstructured":"Kyriakidi KS, Tsianos VE, Karvounis E, Christodoulou DK, Katsanos KH, Tsianos EV (2016) Neutrophil anti-neutrophil cytoplasmic autoantibody proteins: bactericidal increasing protein, lactoferrin, cathepsin, and elastase as serological markers of inflammatory bowel and other diseases. Ann Gastroenterol 29(3):258\u2013267. https:\/\/doi.org\/10.20524\/aog.2016.0028","journal-title":"Ann Gastroenterol"},{"issue":"6","key":"4062_CR23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.autrev.2010.11.003","volume":"10","author":"I Lochman","year":"2011","unstructured":"Lochman I, Kral V, Lochmanova A, Lupac J, Cebecauer L (2011) ANCA in the diagnosis of neutrophil-mediated inflammation. Autoimmun Rev 10(6):295\u2013298. https:\/\/doi.org\/10.1016\/j.autrev.2010.11.003","journal-title":"Autoimmun Rev"},{"issue":"2","key":"4062_CR24","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1006\/jaut.1993.1016","volume":"6","author":"P Lesavre","year":"1993","unstructured":"Lesavre P, No\u00ebl LH, Gayno S, Nusbaum P, Reumaux D, Erlinger S, Gr\u00fcnfeld JP, Halbwachs-Mecarelli L (1993) Atypical autoantigen targets of perinuclear antineutrophil cytoplasm antibodies (P-ANCA): specificity and clinical associations. J Autoimmun 6(2):185\u2013195. https:\/\/doi.org\/10.1006\/jaut.1993.1016","journal-title":"J Autoimmun"},{"issue":"5","key":"4062_CR25","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.semnephrol.2017.05.016","volume":"37","author":"HL Hutton","year":"2017","unstructured":"Hutton HL, Holdsworth SR, Kitching AR (2017) ANCA-associated vasculitis: pathogenesis, models, and preclinical testing. Semin Nephrol 37(5):418\u2013435. https:\/\/doi.org\/10.1016\/j.semnephrol.2017.05.016","journal-title":"Semin Nephrol"},{"key":"4062_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00467-016-3475-5","volume":"33","author":"D Noone","year":"2016","unstructured":"Noone D, Hebert D, Licht C (2016) Pathogenesis and treatment of ANCA-associated vasculitis\u2014a role for complement. Pediatr Nephrol 33:1\u201311. https:\/\/doi.org\/10.1007\/s00467-016-3475-5","journal-title":"Pediatr Nephrol"},{"issue":"7","key":"4062_CR27","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.autrev.2016.03.007","volume":"15","author":"P-A Jarrot","year":"2016","unstructured":"Jarrot P-A, Kaplanski G (2016) Pathogenesis of ANCA-associated vasculitis: an update. Autoimmun Rev 15(7):704\u2013713. https:\/\/doi.org\/10.1016\/j.autrev.2016.03.007","journal-title":"Autoimmun Rev"},{"issue":"3","key":"4062_CR28","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.autrev.2014.10.020","volume":"14","author":"KN Konstantinov","year":"2015","unstructured":"Konstantinov KN, Ulff-Moller CJ, Tzamaloukas AH (2015) Infections and antineutrophil cytoplasmic antibodies: triggering mechanisms. Autoimmun Rev 14(3):201\u2013203. https:\/\/doi.org\/10.1016\/j.autrev.2014.10.020","journal-title":"Autoimmun Rev"},{"issue":"11","key":"4062_CR29","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.autrev.2015.06.008","volume":"14","author":"N Dumoitier","year":"2015","unstructured":"Dumoitier N, Terrier B, London J, Lofek S, Mouthon L (2015) Implication of B lymphocytes in the pathogenesis of ANCA-associated vasculitides. Autoimmun Rev 14(11):996\u20131004. https:\/\/doi.org\/10.1016\/j.autrev.2015.06.008","journal-title":"Autoimmun Rev"},{"issue":"4","key":"4062_CR30","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000442323","volume":"1","author":"H Xiao","year":"2016","unstructured":"Xiao H, Hu P, Falk RJ, Jennette JC (2016) Overview of the pathogenesis of ANCA-associated vasculitis. Kidney Dis (Basel) 1(4):205\u2013215. https:\/\/doi.org\/10.1159\/000442323","journal-title":"Kidney Dis (Basel)"},{"issue":"8","key":"4062_CR31","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrrheum.2014.103","volume":"10","author":"JC Jennette","year":"2014","unstructured":"Jennette JC, Falk RJ (2014) Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease. Nat Rev Rheumatol 10(8):463\u2013473. https:\/\/doi.org\/10.1038\/nrrheum.2014.103","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"4062_CR32","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.autrev.2011.08.002","volume":"11","author":"N Lepse","year":"2011","unstructured":"Lepse N, Abdulahad WH, Kallenberg CG, Heeringa P (2011) Immune regulatory mechanisms in ANCA-associated vasculitides. Autoimmun Rev 11(2):77\u201383. https:\/\/doi.org\/10.1016\/j.autrev.2011.08.002","journal-title":"Autoimmun Rev"},{"issue":"4","key":"4062_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11926-017-0641-0","volume":"19","author":"EJ Gapud","year":"2017","unstructured":"Gapud EJ, Seo P, Antiochos B (2017) ANCA-associated vasculitis pathogenesis: a commentary. Curr Rheumatol Rep 19(4):15. https:\/\/doi.org\/10.1007\/s11926-017-0641-0","journal-title":"Curr Rheumatol Rep"},{"key":"4062_CR34","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000314776","volume":"169","author":"JC Jennette","year":"2011","unstructured":"Jennette JC, Xiao H, Falk R (2011) Experimental models of vasculitis and glomerulonephritis induced by antineutrophil cytoplasmic autoantibodies. Contrib Nephrol 169:211\u2013220. https:\/\/doi.org\/10.1159\/000314776","journal-title":"Contrib Nephrol"},{"issue":"4","key":"4062_CR35","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.2353\/ajpath.2009.080458","volume":"174","author":"MA Little","year":"2009","unstructured":"Little MA, Smyth L, Salama AD, Mukherjee S, Smith J, Haskard D, Nourshargh S, Cook HT, Pusey CD (2009) Experimental autoimmune vasculitis: an animal model of anti-neutrophil cytoplasmic autoantibody-associated systemic vasculitis. Am J Pathol 174(4):1212\u20131220. https:\/\/doi.org\/10.2353\/ajpath.2009.080458","journal-title":"Am J Pathol"},{"issue":"4","key":"4062_CR36","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1053\/j.ajkd.2005.01.001","volume":"45","author":"DJ Schlieben","year":"2005","unstructured":"Schlieben DJ, Korbet SM, Kimura RE, Schwartz MM, Lewis EJ (2005) Pulmonary-renal syndrome in a newborn with placental transmission of ANCAs. Am J Kidney Dis 45(4):758\u2013761. https:\/\/doi.org\/10.1053\/j.ajkd.2005.01.001","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"4062_CR37","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.autrev.2012.08.008","volume":"12","author":"A Radice","year":"2013","unstructured":"Radice A, Bianchi L, Sinico RA (2013) Anti-neutrophil cytoplasmic autoantibodies: methodological aspects and clinical significance in systemic vasculitis. Autoimmun Rev 12(4):487\u2013495. https:\/\/doi.org\/10.1016\/j.autrev.2012.08.008","journal-title":"Autoimmun Rev"},{"issue":"7","key":"4062_CR38","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1007\/s10067-016-3195-z","volume":"35","author":"BM Cordova-Sanchez","year":"2016","unstructured":"Cordova-Sanchez BM, Mejia-Vilet JM, Morales-Buenrostro LE, Loyola-Rodriguez G, Uribe-Uribe NO, Correa-Rotter R (2016) Clinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvement. Clin Rheumatol 35(7):1805\u20131816. https:\/\/doi.org\/10.1007\/s10067-016-3195-z","journal-title":"Clin Rheumatol"},{"issue":"1","key":"4062_CR39","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/BOR.0000000000000233","volume":"28","author":"CG Kallenberg","year":"2016","unstructured":"Kallenberg CG (2016) Usefulness of antineutrophil cytoplasmic autoantibodies in diagnosing and managing systemic vasculitis. Curr Opin Rheumatol 28(1):8\u201314. https:\/\/doi.org\/10.1097\/BOR.0000000000000233","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"4062_CR40","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1046\/j.1365-2249.1999.01006.x","volume":"117","author":"R Mahadeva","year":"1999","unstructured":"Mahadeva R, Dunn AC, Westerbeek RC, Sharples L, Whitehouse DB, Carroll NR, Ross-Russell RI, Webb AK, Bilton D, Lomas DA, Lockwood CM (1999) Anti-neutrophil cytoplasmic antibodies (ANCA) against bactericidal\/permeability-increasing protein (BPI) and cystic fibrosis lung disease. Clin Exp Immunol 117(3):561\u2013567","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"4062_CR41","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1365-2249.1994.tb06578.x","volume":"97","author":"DJ Pudifin","year":"1994","unstructured":"Pudifin DJ, Duursma J, Gathiram V, Jackson TF (1994) Invasive amoebiasis is associated with the development of anti-neutrophil cytoplasmic antibody. Clin Exp Immunol 97(1):48\u201351","journal-title":"Clin Exp Immunol"},{"issue":"8","key":"4062_CR42","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nrrheum.2014.104","volume":"10","author":"CG Kallenberg","year":"2014","unstructured":"Kallenberg CG (2014) Key advances in the clinical approach to ANCA-associated vasculitis. Nat Rev Rheumatol 10(8):484\u2013493. https:\/\/doi.org\/10.1038\/nrrheum.2014.104","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"4062_CR43","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1002\/art.38389","volume":"66","author":"A Mahr","year":"2014","unstructured":"Mahr A, Batteux F, Tubiana S, Goulvestre C, Wolff M, Papo T, Vrtovsnik F, Klein I, Iung B, Duval X, Group IS (2014) Brief report: prevalence of antineutrophil cytoplasmic antibodies in infective endocarditis. Arthritis Rheumatol 66(6):1672\u20131677. https:\/\/doi.org\/10.1002\/art.38389","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"4062_CR44","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/ki.2010.198","volume":"78","author":"Z Cui","year":"2010","unstructured":"Cui Z, Zhao MH, Segelmark M, Hellmark T (2010) Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals. Kidney Int 78(6):590\u2013597. https:\/\/doi.org\/10.1038\/ki.2010.198","journal-title":"Kidney Int"},{"issue":"12","key":"4062_CR45","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11926-016-0619-3","volume":"18","author":"LE Vega","year":"2016","unstructured":"Vega LE, Espinoza LR (2016) Predictors of poor outcome in ANCA-associated vasculitis (AAV). Curr Rheumatol Rep 18(12):70. https:\/\/doi.org\/10.1007\/s11926-016-0619-3","journal-title":"Curr Rheumatol Rep"},{"issue":"40","key":"4062_CR46","doi-asserted-by":"publisher","first-page":"e5096","DOI":"10.1097\/MD.0000000000005096","volume":"95","author":"E Houben","year":"2016","unstructured":"Houben E, Bax WA, van Dam B, Slieker WA, Verhave G, Frerichs FC, van Eijk IC, Boersma WG, de Kuyper GT, Penne EL (2016) Diagnosing ANCA-associated vasculitis in ANCA positive patients: a retrospective analysis on the role of clinical symptoms and the ANCA titre. Medicine (Baltimore) 95(40):e5096. https:\/\/doi.org\/10.1097\/MD.0000000000005096","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"4062_CR47","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0953-6205(03)00097-9","volume":"14","author":"A Rutgers","year":"2003","unstructured":"Rutgers A, Heeringa P, Damoiseaux JG, Tervaert JW (2003) ANCA and anti-GBM antibodies in diagnosis and follow-up of vasculitic disease. Eur J Intern Med 14(5):287\u2013295","journal-title":"Eur J Intern Med"},{"issue":"5","key":"4062_CR48","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1590\/1806-9282.62.05.434","volume":"62","author":"VM Domingues","year":"1992","unstructured":"Domingues VM, Machado B (1992) Santos J (2016) ANCA-positive vasculitis: clinical implications of ANCA types and titers. Rev Assoc Med Bras 62(5):434\u2013440. https:\/\/doi.org\/10.1590\/1806-9282.62.05.434","journal-title":"Rev Assoc Med Bras"},{"issue":"12","key":"4062_CR49","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s11926-013-0383-6","volume":"15","author":"I Khan","year":"2013","unstructured":"Khan I, Watts RA (2013) Classification of ANCA-associated vasculitis. Curr Rheumatol Rep 15(12):383. https:\/\/doi.org\/10.1007\/s11926-013-0383-6","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"4062_CR50","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1136\/annrheumdis-2012-201750","volume":"72","author":"A Mahr","year":"2013","unstructured":"Mahr A, Katsahian S, Varet H, Guillevin L, Hagen EC, Hoglund P, Merkel PA, Pagnoux C, Rasmussen N, Westman K, Jayne DR, French Vasculitis Study G, the European Vasculitis S (2013) Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis. Ann Rheum Dis 72(6):1003\u20131010. https:\/\/doi.org\/10.1136\/annrheumdis-2012-201750","journal-title":"Ann Rheum Dis"},{"key":"4062_CR51","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s12016-017-8616-5","volume":"53","author":"AV Marzano","year":"2017","unstructured":"Marzano AV, Raimondo MG, Berti E, Meroni PL, Ingegnoli F (2017) Cutaneous manifestations of ANCA-associated small vessels Vasculitis. Clin Rev Allergy Immunol 53:428\u2013438. https:\/\/doi.org\/10.1007\/s12016-017-8616-5","journal-title":"Clin Rev Allergy Immunol"},{"issue":"11","key":"4062_CR52","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.autrev.2014.08.017","volume":"13","author":"C Comarmond","year":"2014","unstructured":"Comarmond C, Cacoub P (2014) Granulomatosis with polyangiitis (Wegener): clinical aspects and treatment. Autoimmun Rev 13(11):1121\u20131125. https:\/\/doi.org\/10.1016\/j.autrev.2014.08.017","journal-title":"Autoimmun Rev"},{"issue":"1","key":"4062_CR53","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.amjmed.2004.02.030","volume":"117","author":"P Seo","year":"2004","unstructured":"Seo P, Stone JH (2004) The antineutrophil cytoplasmic antibody-associated vasculitides. Am J Med 117(1):39\u201350. https:\/\/doi.org\/10.1016\/j.amjmed.2004.02.030","journal-title":"Am J Med"},{"issue":"2","key":"4062_CR54","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1177\/0394632015617063","volume":"29","author":"A Greco","year":"2016","unstructured":"Greco A, Marinelli C, Fusconi M, Macri GF, Gallo A, De Virgilio A, Zambetti G, de Vincentiis M (2016) Clinic manifestations in granulomatosis with polyangiitis. Int J Immunopathol Pharmacol 29(2):151\u2013159. https:\/\/doi.org\/10.1177\/0394632015617063","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"10","key":"4062_CR55","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.autrev.2016.07.016","volume":"15","author":"M Weiner","year":"2016","unstructured":"Weiner M, Segelmark M (2016) The clinical presentation and therapy of diseases related to anti-neutrophil cytoplasmic antibodies (ANCA). Autoimmun Rev 15(10):978\u2013982. https:\/\/doi.org\/10.1016\/j.autrev.2016.07.016","journal-title":"Autoimmun Rev"},{"issue":"8","key":"4062_CR56","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1002\/art.1780330807","volume":"33","author":"RY Leavitt","year":"1990","unstructured":"Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, Calabrese LH, Fries JF, Lie JT, Lightfoot RW Jr et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener\u2019s granulomatosis. Arthritis Rheum 33(8):1101\u20131107","journal-title":"Arthritis Rheum"},{"issue":"5","key":"4062_CR57","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1136\/ard.2006.062711","volume":"66","author":"B Hellmich","year":"2007","unstructured":"Hellmich B, Flossmann O, Gross WL, Bacon P, Cohen-Tervaert JW, Guillevin L, Jayne D, Mahr A, Merkel PA, Raspe H, Scott DG, Witter J, Yazici H, Luqmani RA (2007) EULAR recommendations for conducting clinical studies and\/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis 66(5):605\u2013617. https:\/\/doi.org\/10.1136\/ard.2006.062711","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"4062_CR58","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1002\/art.39812","volume":"68","author":"EM Miloslavsky","year":"2016","unstructured":"Miloslavsky EM, Lu N, Unizony S, Choi HK, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Tchao NK, Fervenza F, Monach PA, Specks U, Stone JH (2016) Myeloperoxidase-antineutrophil cytoplasmic antibody (ANCA)-positive and ANCA-negative patients with granulomatosis with polyangiitis (Wegener\u2019s): distinct patient subsets. Arthritis Rheumatol 68(12):2945\u20132952. https:\/\/doi.org\/10.1002\/art.39812","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"4062_CR59","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1136\/ard.2010.130203","volume":"69","author":"JU Holle","year":"2010","unstructured":"Holle JU, Gross WL, Holl-Ulrich K, Ambrosch P, Noelle B, Both M, Csernok E, Moosig F, Schinke S, Reinhold-Keller E (2010) Prospective long-term follow-up of patients with localised Wegener\u2019s granulomatosis: does it occur as persistent disease stage? Ann Rheum Dis 69(11):1934\u20131939. https:\/\/doi.org\/10.1136\/ard.2010.130203","journal-title":"Ann Rheum Dis"},{"key":"4062_CR60","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jaut.2014.01.023","volume":"48-49","author":"CG Kallenberg","year":"2014","unstructured":"Kallenberg CG (2014) The diagnosis and classification of microscopic polyangiitis. J Autoimmun 48-49:90\u201393. https:\/\/doi.org\/10.1016\/j.jaut.2014.01.023","journal-title":"J Autoimmun"},{"issue":"9533","key":"4062_CR61","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S0140-6736(06)69114-9","volume":"368","author":"X Bosch","year":"2006","unstructured":"Bosch X, Guilabert A, Font J (2006) Antineutrophil cytoplasmic antibodies. Lancet 368(9533):404\u2013418. https:\/\/doi.org\/10.1016\/S0140-6736(06)69114-9","journal-title":"Lancet"},{"key":"4062_CR62","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s40620-017-0412-z","volume":"31","author":"V Binda","year":"2017","unstructured":"Binda V, Moroni G, Messa P (2017) ANCA-associated vasculitis with renal involvement. J Nephrol 31:197\u2013208. https:\/\/doi.org\/10.1007\/s40620-017-0412-z","journal-title":"J Nephrol"},{"issue":"2","key":"4062_CR63","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2340\/00015555-0034","volume":"86","author":"T Kawakami","year":"2006","unstructured":"Kawakami T, Soma Y, Saito C, Ogawa H, Nagahuchi Y, Okazaki T, Ozaki S, Mizoguchi M (2006) Cutaneous manifestations in patients with microscopic polyangiitis: two case reports and a minireview. Acta Derm Venereol 86(2):144\u2013147. https:\/\/doi.org\/10.2340\/00015555-0034","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"4062_CR64","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1136\/ard.2009.109389","volume":"69","author":"MA Little","year":"2010","unstructured":"Little MA, Nightingale P, Verburgh CA, Hauser T, De Groot K, Savage C, Jayne D, Harper L, European Vasculitis Study G (2010) Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis. Ann Rheum Dis 69(6):1036\u20131043. https:\/\/doi.org\/10.1136\/ard.2009.109389","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"4062_CR65","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1136\/ard.2007.071936","volume":"67","author":"C Mukhtyar","year":"2008","unstructured":"Mukhtyar C, Flossmann O, Hellmich B, Bacon P, Cid M, Cohen-Tervaert JW, Gross WL, Guillevin L, Jayne D, Mahr A, Merkel PA, Raspe H, Scott D, Witter J, Yazici H, Luqmani RA, European Vasculitis Study G (2008) Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force. Ann Rheum Dis 67(7):1004\u20131010. https:\/\/doi.org\/10.1136\/ard.2007.071936","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4062_CR66","first-page":"111","volume":"103","author":"J Yoo","year":"2017","unstructured":"Yoo J, Kim HJ, Ahn SS, Jung SM, Song JJ, Park YB, Lee SW (2017) Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis. Clin Exp Rheumatol 35 Suppl 103(1):111\u2013118","journal-title":"Clin Exp Rheumatol 35 Suppl"},{"issue":"4","key":"4062_CR67","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s10067-015-3086-8","volume":"35","author":"S Shah","year":"2016","unstructured":"Shah S, Havill J, Rahman MH, Geetha D (2016) A historical study of American patients with anti-neutrophil cytoplasmic antibody negative pauci-immune glomerulonephritis. Clin Rheumatol 35(4):953\u2013960. https:\/\/doi.org\/10.1007\/s10067-015-3086-8","journal-title":"Clin Rheumatol"},{"issue":"8","key":"4062_CR68","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1002\/art.1780330806","volume":"33","author":"AT Masi","year":"1990","unstructured":"Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY et al (1990) The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33(8):1094\u20131100","journal-title":"Arthritis Rheum"},{"issue":"9","key":"4062_CR69","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1002\/art.21250","volume":"52","author":"RA Sinico","year":"2005","unstructured":"Sinico RA, Di Toma L, Maggiore U, Bottero P, Radice A, Tosoni C, Grasselli C, Pavone L, Gregorini G, Monti S, Frassi M, Vecchio F, Corace C, Venegoni E, Buzio C (2005) Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum 52(9):2926\u20132935. https:\/\/doi.org\/10.1002\/art.21250","journal-title":"Arthritis Rheum"},{"issue":"2","key":"4062_CR70","doi-asserted-by":"publisher","first-page":"e571","DOI":"10.1016\/j.jaci.2012.05.058","volume":"131","author":"B Healy","year":"2013","unstructured":"Healy B, Bibby S, Steele R, Weatherall M, Nelson H, Beasley R (2013) Antineutrophil cytoplasmic autoantibodies and myeloperoxidase autoantibodies in clinical expression of Churg-Strauss syndrome. J Allergy Clin Immunol 131(2):e571\u2013e576. https:\/\/doi.org\/10.1016\/j.jaci.2012.05.058","journal-title":"J Allergy Clin Immunol"},{"issue":"3 Suppl 82","key":"4062_CR71","first-page":"S41","volume":"32","author":"BM Sokolowska","year":"2014","unstructured":"Sokolowska BM, Szczeklik WK, Wludarczyk AA, Kuczia PP, Jakiela BA, Gasior JA, Bartyzel SR, Rewerski PA, Musial J (2014) ANCA-positive and ANCA-negative phenotypes of eosinophilic granulomatosis with polyangiitis (EGPA): outcome and long-term follow-up of 50 patients from a single Polish center. Clin Exp Rheumatol 32(3 Suppl 82):S41\u2013S47","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"4062_CR72","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/art.37721","volume":"65","author":"C Comarmond","year":"2013","unstructured":"Comarmond C, Pagnoux C, Khellaf M, Cordier JF, Hamidou M, Viallard JF, Maurier F, Jouneau S, Bienvenu B, Puechal X, Aumaitre O, Le Guenno G, Le Quellec A, Cevallos R, Fain O, Godeau B, Seror R, Dunogue B, Mahr A, Guilpain P, Cohen P, Aouba A, Mouthon L, Guillevin L, French Vasculitis Study G (2013) Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum 65(1):270\u2013281. https:\/\/doi.org\/10.1002\/art.37721","journal-title":"Arthritis Rheum"},{"issue":"6","key":"4062_CR73","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1136\/annrheumdis-2012-201531","volume":"72","author":"F Moosig","year":"2013","unstructured":"Moosig F, Bremer JP, Hellmich B, Holle JU, Holl-Ulrich K, Laudien M, Matthis C, Metzler C, Nolle B, Richardt G, Gross WL (2013) A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients. Ann Rheum Dis 72(6):1011\u20131017. https:\/\/doi.org\/10.1136\/annrheumdis-2012-201531","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"4062_CR74","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/art.39639","volume":"68","author":"JH Koh","year":"2016","unstructured":"Koh JH, Kemna MJ, Cohen Tervaert JW, Kim WU (2016) Editorial: can an increase in antineutrophil cytoplasmic autoantibody titer predict relapses in Antineutrophil cytoplasmic antibody-associated vasculitis? Arthritis Rheumatol 68(7):1571\u20131573. https:\/\/doi.org\/10.1002\/art.39639","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"4062_CR75","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1681\/ASN.2013111233","volume":"26","author":"MJ Kemna","year":"2015","unstructured":"Kemna MJ, Damoiseaux J, Austen J, Winkens B, Peters J, van Paassen P, Cohen Tervaert JW (2015) ANCA as a predictor of relapse: useful in patients with renal involvement but not in patients with nonrenal disease. Journal America Soc Nephrology : JASN 26(3):537\u2013542. https:\/\/doi.org\/10.1681\/ASN.2013111233","journal-title":"Journal America Soc Nephrology : JASN"},{"issue":"8","key":"4062_CR76","doi-asserted-by":"publisher","first-page":"e0182549","DOI":"10.1371\/journal.pone.0182549","volume":"12","author":"J Land","year":"2017","unstructured":"Land J, Abdulahad WH, Arends S, Sanders J-SF, Stegeman CA, Heeringa P, Rutgers A (2017) Prospective monitoring of in vitro produced PR3-ANCA does not improve relapse prediction in granulomatosis with polyangiitis. PLoS One 12(8):e0182549. https:\/\/doi.org\/10.1371\/journal.pone.0182549","journal-title":"PLoS One"},{"issue":"1\u20132","key":"4062_CR77","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1159\/000442934","volume":"34","author":"G Zhou","year":"2016","unstructured":"Zhou G, Song Y, Yang W, Guo Y, Fang L, Chen Y, Liu Z (2016) ASCA, ANCA, ALCA and many more: are they useful in the diagnosis of inflammatory bowel disease? Dig Dis 34(1\u20132):90\u201397. https:\/\/doi.org\/10.1159\/000442934","journal-title":"Dig Dis"},{"issue":"5","key":"4062_CR78","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s12664-011-0127-3","volume":"30","author":"D Bouzid","year":"2011","unstructured":"Bouzid D, Haddouk S, Amouri A, Ben Hadj Hmida Y, Tahri N, Masmoudi H (2011) Contribution of immunofluorescence to identification and characterization of antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Indian J Gastroenterol 30(5):229\u2013232. https:\/\/doi.org\/10.1007\/s12664-011-0127-3","journal-title":"Indian J Gastroenterol"},{"issue":"5","key":"4062_CR79","doi-asserted-by":"publisher","first-page":"275","DOI":"10.5114\/pg.2013.38728","volume":"8","author":"A Moniuszko","year":"2013","unstructured":"Moniuszko A, Wisniewska A, Rydzewska G (2013) Biomarkers in management of inflammatory bowel disease. Prz Gastroenterol 8(5):275\u2013283. https:\/\/doi.org\/10.5114\/pg.2013.38728","journal-title":"Prz Gastroenterol"},{"issue":"4\u20135","key":"4062_CR80","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.autrev.2014.01.028","volume":"13","author":"K Conrad","year":"2014","unstructured":"Conrad K, Roggenbuck D, Laass MW (2014) Diagnosis and classification of ulcerative colitis. Autoimmun Rev 13(4\u20135):463\u2013466. https:\/\/doi.org\/10.1016\/j.autrev.2014.01.028","journal-title":"Autoimmun Rev"},{"issue":"Suppl 2","key":"4062_CR81","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00508-010-1344-y","volume":"122","author":"E Homsak","year":"2010","unstructured":"Homsak E, Micetic-Turk D, Bozic B (2010) Autoantibodies pANCA, GAB and PAB in inflammatory bowel disease: prevalence, characteristics and diagnostic value. Wien Klin Wochenschr 122(Suppl 2):19\u201325. https:\/\/doi.org\/10.1007\/s00508-010-1344-y","journal-title":"Wien Klin Wochenschr"},{"key":"4062_CR82","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nrrheum.2017.140","volume":"13","author":"X Bossuyt","year":"2017","unstructured":"Bossuyt X, Cohen Tervaert J-W, Arimura Y, Blockmans D, Flores-Suarez LF, Guillevin L, Hellmich B, Jayne D, Jennette JC, Kallenberg CGM, Moiseev S, Novikov P, Radice A, Savige JA, Sinico RA, Specks U, van Paassen P, M-h Z, Rasmussen N, Damoiseaux J, Csernok E (2017) Position paper: revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis. Nat Rev Rheumatol Advance Online Publication 13:683\u2013692. https:\/\/doi.org\/10.1038\/nrrheum.2017.140","journal-title":"Nat Rev Rheumatol Advance Online Publication"},{"key":"4062_CR83","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.cca.2013.06.005","volume":"424","author":"M Mahler","year":"2013","unstructured":"Mahler M, Bogdanos DP, Pavlidis P, Fritzler MJ, Csernok E, Damoiseaux J, Bentow C, Shums Z, Forbes A, Norman GL (2013) PR3-ANCA: a promising biomarker for ulcerative colitis with extensive disease. Clin Chim Acta 424:267\u2013273. https:\/\/doi.org\/10.1016\/j.cca.2013.06.005","journal-title":"Clin Chim Acta"},{"key":"4062_CR84","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jaut.2013.08.001","volume":"46","author":"R Liberal","year":"2013","unstructured":"Liberal R, Mieli-Vergani G, Vergani D (2013) Clinical significance of autoantibodies in autoimmune hepatitis. J Autoimmun 46:17\u201324. https:\/\/doi.org\/10.1016\/j.jaut.2013.08.001","journal-title":"J Autoimmun"},{"issue":"4\u20135","key":"4062_CR85","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.autrev.2014.01.040","volume":"13","author":"KK Yimam","year":"2014","unstructured":"Yimam KK, Bowlus CL (2014) Diagnosis and classification of primary sclerosing cholangitis. Autoimmun Rev 13(4\u20135):445\u2013450. https:\/\/doi.org\/10.1016\/j.autrev.2014.01.040","journal-title":"Autoimmun Rev"},{"issue":"11","key":"4062_CR86","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1111\/apm.12442","volume":"123","author":"AG Sener","year":"2015","unstructured":"Sener AG (2015) Autoantibodies in autoimmune liver diseases. APMIS 123(11):915\u2013919. https:\/\/doi.org\/10.1111\/apm.12442","journal-title":"APMIS"},{"issue":"3","key":"4062_CR87","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/liv.13238","volume":"37","author":"JR Hov","year":"2017","unstructured":"Hov JR, Boberg KM, Taraldsrud E, Vesterhus M, Boyadzhieva M, Solberg IC, Schrumpf E, Vatn MH, Lie BA, Molberg O, Karlsen TH (2017) Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis. Liver Int 37(3):458\u2013465. https:\/\/doi.org\/10.1111\/liv.13238","journal-title":"Liver Int"},{"issue":"1","key":"4062_CR88","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/BOR.0000000000000014","volume":"26","author":"WF Pendergraft 3rd","year":"2014","unstructured":"Pendergraft WF 3rd, Niles JL (2014) Trojan horses: drug culprits associated with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis. Curr Opin Rheumatol 26(1):42\u201349. https:\/\/doi.org\/10.1097\/BOR.0000000000000014","journal-title":"Curr Opin Rheumatol"},{"issue":"7","key":"4062_CR89","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.2215\/CJN.01910215","volume":"10","author":"JJ Hogan","year":"2015","unstructured":"Hogan JJ, Markowitz GS, Radhakrishnan J (2015) Drug-induced glomerular disease: immune-mediated injury. Clin J Am Soc Nephrol 10(7):1300\u20131310. https:\/\/doi.org\/10.2215\/CJN.01910215","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"4062_CR90","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.berh.2004.10.003","volume":"19","author":"J Savige","year":"2005","unstructured":"Savige J, Pollock W, Trevisin M (2005) What do antineutrophil cytoplasmic antibodies (ANCA) tell us? Best Pract Res Clin Rheumatol 19(2):263\u2013276. https:\/\/doi.org\/10.1016\/j.berh.2004.10.003","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"2","key":"4062_CR91","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1742-1241.2006.01250.x","volume":"63","author":"MO Cin","year":"2009","unstructured":"Cin MO, Gursoy A, Morris Y, Aydintug OT, Kamel N, Gullu S (2009) Prevalence and clinical significance of antineutrophil cytoplasmic antibody in Graves\u2019 patients treated with propylthiouracil. Int J Clin Pract 63(2):299\u2013302. https:\/\/doi.org\/10.1111\/j.1742-1241.2006.01250.x","journal-title":"Int J Clin Pract"},{"issue":"2","key":"4062_CR92","doi-asserted-by":"publisher","first-page":"30632","DOI":"10.3402\/jchimp.v6.30632","volume":"6","author":"F Babar","year":"2016","unstructured":"Babar F, Posner JN, Obah EA (2016) Hydralazine-induced pauci-immune glomerulonephritis: intriguing case series with misleading diagnoses. J Community Hosp Intern Med Perspect 6(2):30632. https:\/\/doi.org\/10.3402\/jchimp.v6.30632","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"4062_CR93","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/ced.13085","volume":"42","author":"C Desvignes","year":"2017","unstructured":"Desvignes C, Becquart C, Launay D, Terriou L, Patenotre P, Deheul S, Peytavin G, Dupin N, Delaporte E, Staumont-Salle D (2017) Extensive levamisole-induced vasculitis. Clin Exp Dermatol 42:413\u2013415","journal-title":"Clin Exp Dermatol"},{"issue":"12","key":"4062_CR94","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11926-015-0545-9","volume":"17","author":"RG Grau","year":"2015","unstructured":"Grau RG (2015) Drug-induced vasculitis: new insights and a changing lineup of suspects. Curr Rheumatol Rep 17(12):71. https:\/\/doi.org\/10.1007\/s11926-015-0545-9","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"4062_CR95","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/s11926-012-0283-1","volume":"14","author":"LR Espinoza","year":"2012","unstructured":"Espinoza LR, Perez Alamino R (2012) Cocaine-induced vasculitis: clinical and immunological spectrum. Curr Rheumatol Rep 14(6):532\u2013538. https:\/\/doi.org\/10.1007\/s11926-012-0283-1","journal-title":"Curr Rheumatol Rep"},{"issue":"5","key":"4062_CR96","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1001\/jama.293.5.581","volume":"293","author":"Z Li","year":"2005","unstructured":"Li Z, Kosorok MR, Farrell PM, Laxova A, West SE, Green CG, Collins J, Rock MJ, Splaingard ML (2005) Longitudinal development of mucoid pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA 293(5):581\u2013588. https:\/\/doi.org\/10.1001\/jama.293.5.581","journal-title":"JAMA"},{"issue":"5","key":"4062_CR97","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1183\/09031936.00006009","volume":"34","author":"F Lachenal","year":"2009","unstructured":"Lachenal F, Nkana K, Nove-Josserand R, Fabien N, Durieu I (2009) Prevalence and clinical significance of auto-antibodies in adults with cystic fibrosis. Eur Respir J 34(5):1079\u20131085. https:\/\/doi.org\/10.1183\/09031936.00006009","journal-title":"Eur Respir J"},{"key":"4062_CR98","doi-asserted-by":"publisher","unstructured":"Lindberg U, Carlsson M, Hellmark T, Segelmark M (2015) BPI-ANCA provides additional clinical information to anti-pseudomonas serology: results from a cohort of 117 Swedish cystic fibrosis patients. J Immunol Res 2015:947934. doi: https:\/\/doi.org\/10.1155\/2015\/947934 , 1, 8","DOI":"10.1155\/2015\/947934"},{"issue":"3","key":"4062_CR99","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jcf.2006.10.005","volume":"6","author":"M Carlsson","year":"2007","unstructured":"Carlsson M, Eriksson L, Pressler T, Kornfalt R, Mared L, Meyer P, Wiik A, Wieslander J, Segelmark M (2007) Autoantibody response to BPI predict disease severity and outcome in cystic fibrosis. J Cyst Fibros 6(3):228\u2013233. https:\/\/doi.org\/10.1016\/j.jcf.2006.10.005","journal-title":"J Cyst Fibros"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-018-4062-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4062-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4062-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T16:58:35Z","timestamp":1570899515000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-018-4062-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,10]]},"references-count":99,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["4062"],"URL":"https:\/\/doi.org\/10.1007\/s10067-018-4062-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,10]]},"assertion":[{"value":"9 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}